Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum HLS Therapeutics Inc T.HLS

Alternate Symbol(s):  HLTRF

Healthcare Industrials Auto Parts Diversified Industrials
HLS Therapeutics Inc. is a pharmaceutical company focused on the acquisition and commercialization of late-stage development, commercial stage promoted and established branded pharmaceutical products in the North American markets. It is engaged in addressing unmet needs in the treatment of psychiatric disorders and cardiovascular disease. It is also focused on products targeting the central... see more

Bullboard (TSX:HLS)

View:
1 2 Next
Comment by screamer99on Jul 29, 2024 8:13pm

RE:BC Drug Plan

Now we know what that 400k+ (hitting the ask) trade was about last Wednesday.  Took a little longer than expected for the AB Drug Plan, but now we're here. Will take several quarters for ...more  
129
Discussion
Post by screamer99on Feb 06, 2024 12:24pm

BC Drug Plan

Discussion boards are dead everywhere I can see, but the reimbursement from BC is big news. Last March, when it was announced that discussions were ongoing, this stock fell from $8 to where it is now ...more  
238
Discussion
Post by Possibleidiot01on Jun 12, 2023 6:48am

not just one but two cantechletter.com articles

May provide a volume lift ? HLS Therapeutics is still a buy, says Stifel It’s been a rough ride these past two years for fans of specialty pharma company HLS Therapeutics (HLS Therapeutics ...more  
342
Discussion
Post by Pat123on May 10, 2023 2:23pm

Dividend

Expecting a dividend cut tomorrow. Poorly managed co. avoid at all cost
129
Comment by microcaptton Apr 17, 2023 3:39pm

RE:Anyone following HLS still?

IMO the stock is dirt cheap.  Valuation is less now than when they went public.  At that time the stock valuation was primarily to the Cloz asset - they didnt even know they had a ...more  
191
Discussion
Post by rationalon Apr 17, 2023 2:08pm

Anyone following HLS still?

BB activity really petered out here. I am still curious about this company, and I note some analysts are still expecting big things from HLS.  Thoughts anyone?
182
Discussion
Post by retiredcfon Apr 28, 2022 7:00am

Clarus Revise Target

4/27/2022 Clarus Securities Reiterated Rating Buy C$26.50
289
Post by retiredcfon Mar 22, 2022 6:58am

Clarus

HLS Therapeutics Reiterated by Clarus Securities C$33.00 Buy
282
Post by retiredcfon Mar 18, 2022 8:19am

Canaccord

Still looking for a double. GLTA Canaccord Genuity’s Tania Armstrong-Whitworth lowered her HLS Therapeutics Inc. target by 25 cents to $30.50 with a “buy” rating. The average is $30.58.
251
Post by retiredcfon Mar 17, 2022 9:14am

NR

08:20 AM EDT, 03/17/2022 (MT Newswires) -- HLS Therapeutics Inc. (HLS.TO), a pharmaceutical company focusing on central nervous system and cardiovascular markets, on Thursday reported, in US$, that Q4 ...more  
211
Post by retiredcfon Dec 21, 2021 12:45pm

More Good Looking Targets

A very illiquid stock and a very quiet BB but now might be the time to start paying attention. GLTA HLS THERAPEUTICS (TSE:HLS) ANALYST RATINGS HISTORY 12/16/2021 Raymond James  ...more  
333
Post by retiredcfon Dec 21, 2021 12:42pm

Canaccord 2022 Top Picks

Reopening and public access to bring the pulse back Investment recommendation HLS is a specialty pharma company focused on bringing innovative central nervous system (CNS) and ...more  
332
Post by Betteryear2on Aug 16, 2021 6:44am

Promotional Agreement with Pfizer for Vascepa® in Canada

Agreement enables rapid, efficient and impactful expansion to the primary care physician audience. HLS will continue to focus primarily on specialists while Pfizer will focus primarily on primary ...more  
314
Comment by wannabebuffeton Mar 17, 2021 5:35pm

RE:Q FOUR tomorrow before sunrise!

I was tempted to move out of my position into something else but with the predictions of the analysts I decided to stay in. It has made me a lot of money over the years so a few more to see how ...more  
278
Discussion
1 2 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities